Aveanna Healthcare Holdings (AVAH) Cash & Equivalents (2021 - 2026)

Aveanna Healthcare Holdings (AVAH) has 6 years of Cash & Equivalents data on file, last reported at $193.3 million in Q1 2026.

• Quarterly Cash & Equivalents rose 129.29% year-over-year to $193.3 million in Q1 2026, while the trailing twelve-month figure through Jan 2026 was $193.3 million (up 129.29% YoY) and the FY2026 annual result came in at $193.3 million, up 129.29% from the prior year.
• Cash & Equivalents advanced to $193.3 million in Q1 2026, from $145.9 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $193.3 million in Q1 2026 to a low of $17.4 million in Q2 2022.
• A 5-year average of $62.8 million and a median of $47.7 million in 2024 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents tumbled 83.61% — and 2026, when it jumped 129.29%.
• Tracing AVAH's Cash & Equivalents over 5 years: stood at $19.2 million in 2022, then soared by 128.66% to $43.9 million in 2023, then soared by 91.82% to $84.3 million in 2024, then jumped by 73.06% to $145.9 million in 2025, then soared by 32.49% to $193.3 million in 2026.
• The last three Cash & Equivalents figures came in at $193.3 million (Q1 2026), $145.9 million (Q3 2025), and $100.7 million (Q2 2025), per Business Quant data.